Patents by Inventor Diane Davidson

Diane Davidson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING LIVER DISEASES
    Publication number: 20240123031
    Abstract: The present disclosure provides a method of treating or preventing a disease or condition associated with fibrosis and/or diabetes in a subject in need thereof comprising subcutaneously administering to the subject one or more effective doses of a fibroblast growth factor 21 (FGF-21) polypeptide, e.g., FGF-21 conjugate, e.g., PEG-FGF-21.
    Type: Application
    Filed: November 24, 2021
    Publication date: April 18, 2024
    Inventors: Edgar Davidson CHARLES, Shuyan DU, Giridhar S. TIRUCHERAI, George Harry KLINGER, Masayuki YAMAGUCHI, Diane Elizabeth SHEVELL
  • WAX WARMING DEVICE
    Publication number: 20190069345
    Abstract: A wax warming machine may removably retain and warm numerous cans of wax cans, enabling safe and sanitary multiple depilatory treatments and a hygienic waxing experience. The present invention may provide that the wax warming device may comprise a pedestal base, at least one heating component, a housing, a toggle switch, a heat adjustment dial, an indicator light, a heating surface, at least one can of wax, and power chord.
    Type: Application
    Filed: August 29, 2017
    Publication date: February 28, 2019
    Inventor: Diane Davidson
  • Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
    Publication number: 20110021594
    Abstract: The present invention provides compounds and methods of administering compounds to a subject that can reduce ?APP production and that is not toxic in a wide range of dosages. The present invention also provides non-carbamate compounds and methods of administering such compounds to a subject that can reduce ?APP production and that is not toxic in a wide range of dosages. It has been discovered that either the racemic or enantiomerically pure non-carbamate compounds can be used to decrease ?APP production.
    Type: Application
    Filed: July 22, 2010
    Publication date: January 27, 2011
    Inventors: Nigel H. Greig, Karen T.Y. Shaw, Qiang-Sheng Yu, Harold W. Holloway, Tada Utsuki, Timothy T. Soncrant, Donald K. Ingram, Arnold Brossi, Anthony Giordano, Gordon Powers, Diane Davidson, Michael Sturgess
  • Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
    Publication number: 20090131501
    Abstract: The present invention provides compounds and methods of administering compounds to a subject that can reduce ?APP production and that is not toxic in a wide range of dosages. The present invention also provides non-carbamate compounds and methods of administering such compounds to a subject that can reduce ?APP production and that is not toxic in a wide range of dosages. It has been discovered that either the racemic or enantiomerically pure non-carbamate compounds can be used to decrease ?APP production.
    Type: Application
    Filed: January 21, 2009
    Publication date: May 21, 2009
    Applicants: TorreyPines Therapeutics, National Institutes of Health (NIH)
    Inventors: Nigel H. Greig, Karen T.Y. Shaw, Qiang-Sheng Yu, Harold W. Holloway, Tada Utsuki, Timothy T. Soncrant, Donald K. Ingram, Arnold Brossi, Anthony Giordano, Gordon Powers, Diane Davidson, Michael Sturgess
  • Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
    Patent number: 7153882
    Abstract: The present invention provides compounds and methods of administering compounds to a subject that can reduce ?APP production and that is not toxic in a wide range of dosages. The present invention also provides non-carbamate compounds and methods of administering such compounds to a subject that can reduce ?APP production and that is not tocix in a wide range of dosages. It has been discovered that either the racemic or enantiomerically pure non-carbamate compounds can be used to decrease ?APP production.
    Type: Grant
    Filed: November 2, 2001
    Date of Patent: December 26, 2006
    Assignees: The United States of America as represented by the Department of Health and Human Services, The National Institutes of Health and Axonyx, Inc.
    Inventors: Nigel H. Greig, Karen T. Y. Shaw, Qiang-Sheng Yu, Harold W. Holloway, Timothy T. Sencrant, Tada Utsuki, Donald Ingram, Arnold Brossi, Anthony Giordano, Gordon Powers, Diane Davidson, Michael Sturgess
  • Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
    Publication number: 20060270729
    Abstract: The present invention provides compounds and methods of administering compounds to a subject that can reduce ?APP production and that is not toxic in a wide range of dosages. The present invention also provides non-carbamate compounds and methods of administering such compounds to a subject that can reduce ?APP production and that is not toxic in a wide range of dosages. It has been discovered that either the racemic or enantiomerically pure non-carbamate compounds can be used to decrease ?APP production.
    Type: Application
    Filed: June 20, 2006
    Publication date: November 30, 2006
    Inventors: Nigel Greig, Karen Shaw, Qiang-Sheng Yu, Harold Holloway, Tada Utsuki, Timothy Soncrant, Donald Ingram, Arnold Brossi, Anthony Giordano, Gordon Powers, Diane Davidson, Michael Sturgess
  • Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
    Publication number: 20040138282
    Abstract: The present invention provides compounds and methods of administering compounds to a subject taht can reduce &bgr;APP production and that is not toxic in a wide range of dosages. The present invention also provides non-carbamate compounds and methods of administering such compounds to a subject that can reduce &bgr;APP production and that is not tocix in a wide range of dosages. It has been discovered that either the racemic or enantiomerically pure non-carbamate compounds can be used to decrease &bgr;APP production.
    Type: Application
    Filed: February 6, 2004
    Publication date: July 15, 2004
    Inventors: Nigel H. Greig, Karen T. Y. Shaw, Qiang-Sheng Yu, Harold W. Holloway, Timothy T. Sencrant, Tada Utsuki, Donald K. Ingram, Arnold Brossi, Anthony Giordano, Gordon Powers, Diane Davidson, Michael Sturgess